A new financing for research into variants will be add to the new research and innovation programme Horizon Europe. The Commission announced on 7 April 2021 that Brussels will mobilise 123 million euros and will launch new calls for tackling coronavirus variants on 13 April 2021.
The Commission launched new calls that complement earlier actions to develop treatments and vaccines by organising and conducting clinical trials to advance the development of promising therapeutics and vaccines against SARS-CoV-2/COVID-19. They will support the development of large scale, COVID-19 cohorts and networks beyond Europe’s borders, forging links with European initiatives, as well as reinforce the infrastructures needed to share data, expertise, research resources and expert services among researchers and research organisations.
The calls will open for submissions on 13 April and the deadline for submission is 6 May 2021.